This paper focuses on the approaches to target glycemic control in patients with type 2 diabetes mellitus. It is emphasized that timely onset of insulintherapy enhances glycemic control and reduces the risk of vascular complications. One way to achieve this goal is to use modern strategies of intensivehypoglycemic therapy with insulins having improved pharmacokinetic and pharmakodynamic properties, e.g. glargine (Lantus) and glulysine (Apidra).Results of international clinical studies confirm effi-ciency of basal and basal-plus insulin strategies allowing to achieve glycemic control in type 2diabetes without heightening the risk of hypoglycemia, development and progression of vascular complications
Achieving target values of glycemic profile — the main objective of therapy for type 2 diabetes mell...
Abstract: The prevalence of Diabetes is progressively increasing world-wide and the growth of the di...
UKPDS and DCCT studies have demonstrated the critical role of tight glycaemic control to reduce the ...
Maintaining glycemic control through intensive clinical management of patients with type 2 diabetes ...
Type 2 diabetes is characterized by chronic hyperglycemia and varying degrees of insulin resistance ...
BBasal insulin provides an effective method for initiating insulin therapy in people with Type 2 dia...
Given the continued interest in defining the optimal management of individuals with type 2 diabetes,...
Diabetes is increasing all around the world like an epidemic. It is creating an alarming situation a...
Glycaemic control in Type 1 diabetes has been proven efficient in preventing microvascular and neuro...
New treatments for patients with type 2 diabetes mellitus. Wolffenbuttel BH, Graal MB. Department of...
60?70% of all patients with Type 2 Diabetes Mellitus will ultimately require insulin therapy for the...
The increasing prevalence, variable pathogenesis, progressive natural history, and complications of ...
Patients with type 2 diabetes mellitus are usually treated initially with oral antidiabetic agents, ...
Achieving and maintaining glycemic control (glycated hemoglobin – HbA1c≤7.0% according to American D...
peer reviewedBecause of the natural history of type 2 diabetes and the increasing life expectancy, m...
Achieving target values of glycemic profile — the main objective of therapy for type 2 diabetes mell...
Abstract: The prevalence of Diabetes is progressively increasing world-wide and the growth of the di...
UKPDS and DCCT studies have demonstrated the critical role of tight glycaemic control to reduce the ...
Maintaining glycemic control through intensive clinical management of patients with type 2 diabetes ...
Type 2 diabetes is characterized by chronic hyperglycemia and varying degrees of insulin resistance ...
BBasal insulin provides an effective method for initiating insulin therapy in people with Type 2 dia...
Given the continued interest in defining the optimal management of individuals with type 2 diabetes,...
Diabetes is increasing all around the world like an epidemic. It is creating an alarming situation a...
Glycaemic control in Type 1 diabetes has been proven efficient in preventing microvascular and neuro...
New treatments for patients with type 2 diabetes mellitus. Wolffenbuttel BH, Graal MB. Department of...
60?70% of all patients with Type 2 Diabetes Mellitus will ultimately require insulin therapy for the...
The increasing prevalence, variable pathogenesis, progressive natural history, and complications of ...
Patients with type 2 diabetes mellitus are usually treated initially with oral antidiabetic agents, ...
Achieving and maintaining glycemic control (glycated hemoglobin – HbA1c≤7.0% according to American D...
peer reviewedBecause of the natural history of type 2 diabetes and the increasing life expectancy, m...
Achieving target values of glycemic profile — the main objective of therapy for type 2 diabetes mell...
Abstract: The prevalence of Diabetes is progressively increasing world-wide and the growth of the di...
UKPDS and DCCT studies have demonstrated the critical role of tight glycaemic control to reduce the ...